date:May 31, 2022
for Cronobacter sakazakii.
With Abbott being one of the four key manufacturers in the country, the factorys closure heightened supply shortages across the country, worsening supply chain issues.
Nonetheless, Abbott is set to reopen its facility following an agreement with the FDA, while the US Federal Trade Commission is launching a public inquiry on how the infant formula industry has become so concentrated.
The US produces 98% of the baby formula for its population, limited to a pool of fou